Defense Advanced Research Projects AgencyTagged Content List

Prevention and Therapy

Biomedical technologies designed to thwart initial infection or injury, or enable faster healing afterward

Showing 60 results for Therapy RSS
Program Manager
Dr. Amy Jenkins joined DARPA as a program manager in the Biological Technologies Office (BTO) in June 2019. Her interests include the development of platforms for combatting infectious disease threats as well as novel manufacturing methods to enable rapid response.
Office Director
Dr. Brad Ringeisen was named Office Director of BTO in June 2019. He joined DARPA as the deputy director of BTO in December 2016.
Program Manager
Dr. Tristan McClure-Begley joined DARPA as a Program Manager in October 2017. His scientific pursuits at the agency involve novel chemical biology approaches to treating disease and injury, and developing methods to accelerate and protect learning and executive functions.
04/22/2021
This announcement seeks revolutionary research ideas for topics not being addressed by ongoing BTO programs or other published solicitations.
09/17/2020
DARPA is soliciting innovative proposals to develop (1) new therapeutics against Department of Defense (DoD)-priority bacterial threats that leverage host-driven protein degradation or deactivation pathways; and (2) a platform capability to rapidly develop, screen, and optimize therapeutics against emerging bacterial threats.